mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.5 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
hyperforin |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.5 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.5 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.5 |